- £2.34m
- £0.39m
- £0.05m
- 14
- 23
- 33
- 10
REG - ValiRx PLC - Cytolytix Commercial update
AnnouncementREG - ValiRx PLC - Commercial update
AnnouncementREG - ValiRx PLC - ValiRx Awarded Grant from Open University
AnnouncementREG - ValiRx PLC - Update on Evaluation Agreement with Stingray Bio
AnnouncementREG - ValiRx PLC - Licensing Agreement with Dominion Biotech Ltd
AnnouncementREG - ValiRx PLC - Collaboration Agreement with Voxcell BioInnovation
AnnouncementREG - ValiRx PLC - Result of AGM
AnnouncementREG - ValiRx PLC - Ambrose Exercise Option on VAL401
AnnouncementREG - ValiRx PLC - ValiRx Investor Webinar
AnnouncementREG - ValiRx PLC - Holding(s) in Company
AnnouncementREG - ValiRx PLC - Final Results & Notice of AGM
AnnouncementREG - ValiRx PLC - New Evaluation and Material Transfer Agreement
AnnouncementREG - ValiRx PLC - Holding(s) in Company
AnnouncementREG - ValiRx PLC - Inaphaea Deal Extension With Dominion
AnnouncementREG - ValiRx PLC - Commercial Update
AnnouncementREG - ValiRx PLC - Termination of Letter of Intent with TheoremRx
AnnouncementREG - ValiRx PLC - Directorate Changes and new Advisory Board
AnnouncementREG - ValiRx PLC - Director Disclosure Update
AnnouncementREG - ValiRx PLC - Conclusion of Evaluation Project
Announcement